Sai Krishna S B

Dr. Sai Krishna S B

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
STSai M. Thota
Sai M. Thota
SRSaiswaroop Rajaratnam
Saiswaroop Rajaratnam
SBSai Krishna S B
Sai Krishna S B
SPSujith K. Pulukool
Sujith K. Pulukool
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan
Huntington disease (HD) is a neurodegenerative disease associated with polyglutamine expansion in the protein huntingtin (HTT). Although the length of the polyglutamine repeat correlates with age at disease onset and severity, psychological, cognitive and behavioral complications point to the existence of disease modifiers. Mitochondrial dysfunction and metabolic deregulation are both associated with the HD but, despite multi-omics characterization of patients and model systems, their mechanisms have remained elusive. Systems analysis of multi-omics data and its validation by using a yeast model could help to elucidate pathways that modulate protein aggregation. Metabolomics analysis of HD patients and of a yeast model of HD was, therefore, carried out. Our analysis showed a considerable overlap of deregulated metabolic pathways. Further, the multi-omics analysis showed deregulated pathways common in human, mice and yeast model systems, and those that are unique to them. The deregulated pathways include metabolic pathways of various amino acids, glutathione metabolism, longevity, autophagy and mitophagy. The addition of certain metabolites as well as gene knockouts targeting the deregulated metabolic and autophagy pathways in the yeast model system showed that these pathways do modulate protein aggregation. Taken together, our results showed that the modulation of deregulated pathways influences protein aggregation in HD, and has implications for progression and prognosis.This article has an associated First Person interview with the first author of the paper.

1 September 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SBSai Krishna S B
Sai Krishna S B
SPSujith Kumar Pulukool
Sujith Kumar Pulukool
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
SRSaiswaroop R.
Saiswaroop R.
ANAshwin Ashok Naik
Ashwin Ashok Naik
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan
Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease leading to inflammation, cartilage cell death, synoviocyte proliferation, and increased and impaired differentiation of osteoclasts and osteoblasts leading to joint erosions and deformities. Transcriptomics, proteomics, and metabolomics datasets were analyzed to identify the critical pathways that drive the RA pathophysiology. Single nucleotide polymorphisms (SNPs) associated with RA were analyzed for the functional implications, clinical outcomes, and blood parameters later validated by literature. SNPs associated with RA were grouped into pathways that drive the immune response and cytokine production. Further gene set enrichment analysis (GSEA) was performed on gene expression omnibus (GEO) data sets of peripheral blood mononuclear cells (PBMCs), synovial macrophages, and synovial biopsies from RA patients showed enrichment of Th1, Th2, Th17 differentiation, viral and bacterial infections, metabolic signalling and immunological pathways with potential implications for RA. The proteomics data analysis presented pathways with genes involved in immunological signaling and metabolic pathways, including vitamin B12 and folate metabolism. Metabolomics datasets analysis showed significant pathways like amino-acyl tRNA biosynthesis, metabolism of amino acids (arginine, alanine aspartate, glutamate, glutamine, phenylalanine, and tryptophan), and nucleotide metabolism. Furthermore, our commonality analysis of multi-omics datasets identified common pathways with potential implications for joint remodeling in RA. Disease-modifying anti-rheumatic drugs (DMARDs) and biologics treatments were found to modulate many of the pathways that were deregulated in RA. Overall, our analysis identified molecular signatures associated with the observed symptoms, joint erosions, potential biomarkers, and therapeutic targets in RA. Communicated by Ramaswamy H. Sarma

24 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
SRSaiswaroop Rajaratnam
Saiswaroop Rajaratnam
ASAkhil P. Soman
Akhil P. Soman
KPKanikaram Sai Phalguna
Kanikaram Sai Phalguna
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
MMMeghana Manjunath
Meghana Manjunath
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan
Amyotrophic lateral sclerosis (ALS) is a multi-systemic, incurable, amyloid disease affecting the motor neurons, resulting in the death of patients. The disease is either sporadic or familial with SOD1, C9orf72, FUS, and TDP-43 constituting the majority of familial ALS. Multi-omics studies on patients and model systems like mice and yeast have helped in understanding the association of various signaling and metabolic pathways with the disease. The yeast model system has played a pivotal role in elucidating the gene amyloid interactions. We carried out an integrated transcriptomic and metabolomic analysis of the TDP-43 expressing yeast model to elucidate deregulated pathways associated with the disease. The analysis shows the deregulation of the TCA cycle, single carbon metabolism, glutathione metabolism, and fatty acid metabolism. Transcriptomic analysis of GEO datasets of TDP-43 expressing motor neurons from mice models of ALS and ALS patients shows considerable overlap with experimental results. Furthermore, a yeast model was used to validate the obtained results using metabolite addition and gene knock-out experiments. Taken together, our result shows a potential role for the TCA cycle, cellular redox pathway, NAD metabolism, and fatty acid metabolism in disease. Supplementation of reduced glutathione, nicotinate, and the keto diet might help to manage the disease.


6 March 2026 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
SRSaiswaroop Rajaratnam
Saiswaroop Rajaratnam
VDV. M. Datta Darshan
V. M. Datta Darshan
ANAshwin Ashok Naik
Ashwin Ashok Naik
SBSai Krishna S B
Sai Krishna S B
DKDr. Vishnu Kannan
Dr. Vishnu Kannan
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan